Pfizer, Trump
Digest more
Money Talks News on MSN
Pfizer's 2025 COVID Vaccine Boosts Immunity 4x, Access Severely Limited Nationwide
Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans unable to access the shots.
The pharmacists at Trillium Health Center say they’re able to provide the Moderna and Pfizer COVID-19 vaccine to anyone 12 and older.
It can be hard to sort through the conflicting and evolving information about vaccines. Here’s the latest guidance on Covid boosters, flu shots, childhood immunizations and more.
Health experts are on the verge of possibly having two COVID-19 vaccines and ABC13 has learned how the two compare. SEE RELATED STORY: US COVID-19 vaccinations ramp up as Moderna shot nears authorization According to the FDA, the Moderna vaccine was 94.1% ...
Pfizer (NYSE: PFE) has a huge 7.1% dividend yield. That certainly compares favorably to the broader market's 1.2% yield and the average healthcare stock's yield of 1.7%. But Pfizer's lofty yield only exists because of a worrying 55% stock price decline since late 2022.
As one of the world’s largest biopharma companies, Pfizer ($PFE) is no stranger to leveraging market dynamics to benefit the company and its